StockData
Silence Therapeutics plc logo

Silence Therapeutics plc (SLN) stock

SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$19.81+0.00 (0.00%)

Close on Nov 20, 2026Market cap $935.96MP/E –Yield –

Silence Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Silence Therapeutics's revenue for the twelve months ending Sep 30, 2026 was $456.00K, down 98.2% year over year. For fiscal 2025 it was $559.00K, down 98.7% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$559.00K-98.7%
FY2024Dec 31, 2024$43.26M+36.7%
FY2023Dec 31, 2023$31.64M+46.1%
FY2022Dec 31, 2022$21.66M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$0-100.0%
Q2 FY2026Jun 30, 2026$0-100.0%
Q1 FY2026Mar 31, 2026$422.00K+197.2%
Q4 FY2025Dec 31, 2025$34.00K-99.9%
Q3 FY2025Sep 30, 2025$159.00K-89.4%
Q2 FY2025Jun 30, 2025$224.00K-70.4%
Q1 FY2025Mar 31, 2025$142.00K-99.1%
Q4 FY2024Dec 31, 2024$25.31M–
Q3 FY2024Sep 30, 2024$1.50M–
Q2 FY2024Jun 30, 2024$756.00K–
Q1 FY2024Mar 31, 2024$15.70M–

More Silence Therapeutics figures

See a number that looks wrong?